Clinical Trials in Minneapolis

Showing 11941-11960 of 12,418 trials

Safety/Efficacy of Everolimus and Neoral® in Adult Cardiac Transplant Patients With Established Allograft Vasculopathy

NCT00097968

Everolimus is an immunosuppressive drug that is being studied for preventing acute rejection that can happen after heart transplantation. It is usually used in combination with other immunosuppressive drugs such as cyclosporine. The purpose of this study is to evaluate the change in kidney function after beginning everolimus, while determining the most effective Neoral® (cyclosporine) dose to take with everolimus, in adult cardiac transplant patients who have had their transplanted heart for at least 1 year and who have cardiac allograft vasculopathy.

Graft Rejection

Novartis PharmaceuticalsStarted Aug 2004

Los Angeles, California, United States • Minneapolis, Minnesota, United States • New York, New York, United States +3 more locations

COMPLETEDPhase 2< 1 mile

Dose-finding, Safety and Efficacy Study of NV1FGF in Patients With Intermittent Claudication

NCT01157871

The primary objective is to assess safety and efficacy of two different doses of NV1FGF as compared to placebo. The secondary objective is to assess the pharmacokinetics of NV1FGF and FGF-1 protein.

Peripheral Arterial Occlusive Disease

Sanofi36 participantsStarted Jun 2004

Minneapolis, Minnesota, United States • Brussels, Belgium • Münster, Germany +1 more locations

UNKNOWNPhase 3< 1 mile

SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries

NCT00114972

The SYNTAX trial is designed to determine the best treatment for patients with complex coronary disease (blocked or narrowed arteries in both the right and left sides of the heart) by randomizing patients to receive either percutaneous coronary intervention (PCI) with polymer-based paclitaxel-eluting TAXUS stents or to coronary artery bypass surgery (CABG).

Coronary Artery Disease

Boston Scientific Corporation1,800 participantsStarted Mar 2005

Sacramento, California, United States • Washington D.C., District of Columbia, United States • Atlantis, Florida, United States +103 more locations

Safety/Efficacy of Everolimus and Neoral® in Adult Cardiac Transplant Patients With Established Allograft Vasculopathy

Dose-finding, Safety and Efficacy Study of NV1FGF in Patients With Intermittent Claudication

SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries

Find Trials by Condition in Minneapolis

Efficacy and Safety/Tolerability of Ragweed MATA MPL

Pancreas Allotransplantation for Diabetic Nephropathy and Mild Chronic REnal fAilure Stage Study

Efficacy Study Testing Herbal Extract on Metabolic Parameters in Subjects With Type 2 Diabetes

Comparative Sedation Study of the MyoSure Hysteroscopic Tissue Removal System

Lead Extract Study

PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions

A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe Depression

Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)

A Study Comparing Duloxetine and Placebo in the Treatment of Fibromyalgia

Zinc Supplementation to Reduce Diarrhea Rates in Adults in Western Kenya.

Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV

Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus Aureus

Safety and Efficacy of PROMETRIUM® Capsules in Induction of Secretory Conversion

Effects of Metformin Hydrochloride (HCl) in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus and the Effects of Colesevelam HCl on Lipids and Glucose on Pre-diabetic Patients.

Prevention of Atrial Arrhythmia in Patients Without Atrioventricular (AV) Conduction Disease

Study Evaluating the Effects of AIR645 on Allergen-Induced Airway Responses in Subjects With Mild Atopic Asthma

A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy